Myomo, Inc.

Jurisdiction

United States

LEI

549300G63SSKC2EGLN41

ISIN

US62857J2015

(MYO)

Sectors

Scores

InsiderPie Expert Score: 50 / 100
Even with peer group:: 50 / 100
Fair value (Benjamin Graham formula): N/A
Financial strength (Piotroski F-Value): 3 / 9
Fundamental strength relative to industry (Mohanram G-Value): 4 / 7

Profile

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. Read full profile

Fundamentals

Net revenue: €34.77M
Gross margin: 69.2%
EBIT: -€7.94M
EBIT margin: -22.8%
Net income: -€7.95M
Net margin: -22.9%

Statement period: July 1, 2024 - June 30, 2025 (published August 11, 2025)

Estimates

Fiscal Year	Net revenue	Net income
2026	€41.44M +19.2%	-€9.43M +18.6%
2027	€51.31M +23.8%	-€2.95M -68.7%
2028	€64.16M +25.0%	€6.38M -316.2%

Dividends

No dividend payouts

Analyst ratings

No analyst ratings available

Insider Transactions

Name	Title	Transaction Date	Shares	Price	Value
KIRK THOMAS F	N/A	August 25, 2025	+50K	$1.15	+$57.50K
KIRK THOMAS F	N/A	August 18, 2025	+50K	$1.10	+$55.00K
GUDONIS PAUL R	Chief Executive Officer	August 15, 2025	+50K	$0.95	+$47.50K